Literature DB >> 17458772

Rhinovirus and coronavirus infections.

Stephen B Greenberg1.   

Abstract

Rhinoviruses and coronaviruses cause the majority of common colds and play a part in more serious respiratory illnesses that lead to increased morbidity and mortality. Patients who are infants or elderly, have asthma or chronic obstructive pulmonary disease (COPD), or are immunosuppressed have increased frequency of rhinovirus-related respiratory complications. Newer diagnostic tests such as reverse transcriptase polymerase chain reaction (RT-PCR) have greatly expanded our understanding of the importance of these respiratory viruses. Although there are no currently approved antiviral agents for clinical use, our increased understanding of the virus-host interaction should lead to new intervention strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458772     DOI: 10.1055/s-2007-976490

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  17 in total

1.  [Genius between music and disease: Medical considerations on Ludwig van Beethoven].

Authors:  Elena Romana Gasenzer; Edmund A M Neugebauer
Journal:  Wien Med Wochenschr       Date:  2015-10-19

2.  Effects of aging on the adaptive immune response to respiratory virus infections.

Authors:  Ross B Fulton; Steven M Varga
Journal:  Aging health       Date:  2009-12-01

3.  Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVP.

Authors:  Kenneth H Rand; Howard Rampersaud; Herbert J Houck
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

4.  Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.

Authors:  Jennifer K Quint; Gavin C Donaldson; James J P Goldring; Ramin Baghai-Ravary; John R Hurst; Jadwiga A Wedzicha
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

5.  Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.

Authors:  Manisha Singh; Seung-Hyo Lee; Paul Porter; Chuang Xu; Ayako Ohno; Robert L Atmar; Stephen B Greenberg; Venkata Bandi; Jim Gern; Svetlana Amineva; Alex Aminev; Tim Skern; Pamela Smithwick; Sarah Perusich; Nadia Barrow; Luz Roberts; David B Corry; Farrah Kheradmand
Journal:  J Allergy Clin Immunol       Date:  2010-06       Impact factor: 10.793

Review 6.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12

Review 7.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

8.  Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.

Authors:  Vineet D Menachery; Boyd L Yount; Laurence Josset; Lisa E Gralinski; Trevor Scobey; Sudhakar Agnihothram; Michael G Katze; Ralph S Baric
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

9.  Developing a vaccine for human rhinoviruses.

Authors:  Gary R McLean
Journal:  J Vaccines Immun       Date:  2014-10-01

Review 10.  Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis.

Authors:  Ralph A Tripp
Journal:  Immune Netw       Date:  2013-10-26       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.